• Demographics and administrative data |
• Diagnosis and cause of heart failure |
• Clinical status at admission (NYHA class) |
• Echocardiographic findings and natriuretic peptide levels confirming diagnosis |
• Copy of an electrocardiogram mentioning QRS duration, rhythm, presence of atrioventricular or bundle branch, or fascicular block |
• Laboratory tests results (urea, creatinine, haemoglobin, BNP or NT‐proBNP, and discharge electrolytes) |
• Patient weight at discharge (‘dry weight’) |
• Blood pressure and heart rate at discharge |
• Medications and dosing during hospitalization and following discharge. If no beta‐blockers, MRAs, ACEIs, or, alternatively, ARBs are administered record and document reason |
• Titration instructions and reasons for use of smaller target doses |
• Instructions concerning blood pressure, heart rate, and body weight targets |
• Arrhythmic risk stratification and, on indications, programming for implantation of a cardiac rhythm management device (defibrillator, biventricular pacemaker) |
• Encouragement for daily monitoring of body weight and, in case of abrupt increase—more than 2 kg in 3 days, contact with treating physician |
• Encouragement for smoking cessation and referral to specialized centres |
• Targeted dietary instructions |
• Instructions for administration and monitoring of anticoagulation therapy, on indications, as well as cautions for co‐administration with certain medications (antibiotics) |
• Instructions for annual flu vaccination |
• Instructions for reassessment at a dedicated heart failure outpatient clinic following a laboratory workup (which should be detailed) |
• Names of treating physicians, with attached copies of their instructions |
• Patient information regarding contact details for Heart Failure Outpatient Clinic, both of the discharging hospital and hospitals near patient's residence |